APS vs. PLI, ABCN, EMC, FRX, BCT, IPA, TH, SCYB, COM, and NVH
Should you be buying Aptose Biosciences stock or one of its competitors? The main competitors of Aptose Biosciences include ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), and Novoheart (NVH). These companies are all part of the "biotechnology" industry.
Aptose Biosciences vs.
ProMetic Life Sciences (TSE:PLI) and Aptose Biosciences (TSE:APS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends.
Aptose Biosciences' return on equity of 1,017.48% beat ProMetic Life Sciences' return on equity.
In the previous week, ProMetic Life Sciences' average media sentiment score of 0.00 equaled Aptose Biosciences'average media sentiment score.
15.1% of Aptose Biosciences shares are owned by institutional investors. 17.1% of Aptose Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Given ProMetic Life Sciences' higher possible upside, equities research analysts clearly believe ProMetic Life Sciences is more favorable than Aptose Biosciences.
ProMetic Life Sciences received 229 more outperform votes than Aptose Biosciences when rated by MarketBeat users. However, 72.20% of users gave Aptose Biosciences an outperform vote while only 67.69% of users gave ProMetic Life Sciences an outperform vote.
Aptose Biosciences has lower revenue, but higher earnings than ProMetic Life Sciences. Aptose Biosciences is trading at a lower price-to-earnings ratio than ProMetic Life Sciences, indicating that it is currently the more affordable of the two stocks.
Summary
Aptose Biosciences beats ProMetic Life Sciences on 8 of the 13 factors compared between the two stocks.
Get Aptose Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptose Biosciences Competitors List
Related Companies and Tools
This page (TSE:APS) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy APS Stock Free APS Stock Alerts